Short-term Dual Anti Platelet Therapy in Patients With ACS Treated With the COMBO Dual-therapy Stent

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 1500 participants.

Also called NCT02118870

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 1,500 participants (enrolled count) (from the registry)
Sponsor
Diagram B.V. (from the registry)
Registry
  • NCT NCT02118870
  • EudraCT 2013-005571-40
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
Not reported
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT02118870. Randomized; no masking; primary purpose treatment. Start 2014-06-10 (actual); primary completion 2017-09 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Short-term Dual Anti Platelet Therapy in Patients With ACS Treated With the COMBO Dual-therapy Stent
Acronym
REDUCE
Condition
Acute Coronary Syndrome
Intervention (Drug)
Treatment 90 days DAPT
Intervention (Drug)
Treatment 360 days DAPT
Lead sponsor
Diagram B.V. (class: other)

Record details

Record id
cardio:ct-nct02118870
Content hash
c060b38ef8e25f861579d314a82cd954f5ef0d7f637a3485df6e7ce838563f85